ACB $7.180 (0.7%)

ACNNF $0.091 (6.66%)

AERO $2.980 (1.36%)

AGEEF $0.049 (-8.49%)

ALEAF $0.351 (-2.99%)

AMMJ $0.071 (-14.46%)

APHA $6.360 (3.75%)

ARNA $64.680 (-0.23%)

ATT:CNX $0.080 (0%)

ATTBF $0.007 (-2.26%)

AUSA:CNX $0.200 (0%)

AUSAF $0.146 (-3%)

AVXL $5.150 (-0.39%)

BAMM:CNX $0.440 (4.76%)

BBM:CNX $0.050 (0%)

BBRRF $0.034 (-14.05%)

BE:CNX $0.005 (0%)

BIO:CNX $0.030 (0%)

BLEVF $0.003 (-5.36%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.570 (16.33%)

BLOZF $0.438 (15.37%)

BUDZ $0.233 (1.3%)

BXNG $0.400 (0%)

CADMF $0.259 (-4.17%)

CALI:CNX $0.055 (10%)

CANN $0.436 (-0.85%)

CARA $14.990 (-2.22%)

CBII:CNX $0.490 (5.38%)

CBIIF $0.370 (2.44%)

CBWTF $0.264 (-3.51%)

CGC $24.720 (4.22%)

CGRW $0.089 (-6.37%)

CHOO:CNX $0.080 (6.67%)

CHOOF $0.060 (0.85%)

CNBX $0.297 (5.81%)

CNGGF $0.255 (27.5%)

CODI $19.390 (1.41%)

CPMD $0.390 (0%)

CRBP $1.220 (0.83%)

CRON $7.340 (1.66%)

CROP:CNX $0.015 (0%)

CRTPF $2.040 (-0.49%)

CRXPF $0.025 (0%)

CSI:CNX $0.920 (0%)

CURR $1.050 (0%)

CVSI $0.450 (0.67%)

DIGP $0.019 (4.37%)

DXBRF $0.086 (-3.9%)

EAPH $0.001 (20%)

EAT:CNX $0.005 (-50%)

EEVVF $0.057 (3.17%)

EMHTF $0.160 (-3.03%)

EPWCF $0.073 (7.94%)

EVIO $0.002 (-11.76%)

FFRMF $0.030 (4.35%)

FFT:CNX $0.040 (0%)

FNNZF $0.040 (12.68%)

GGTTF $0.111 (-1.85%)

GLDFF $0.019 (4.19%)

GLH:CNX $0.025 (0%)

GNBT $0.218 (-5.63%)

GRIN:CNX $0.110 (4.76%)

GRWG $31.500 (8.02%)

GTBIF $18.690 (-0.59%)

GTII:CNX $24.500 (-0.28%)

GWPH $125.440 (0.5%)

HEXO $0.727 (1.2%)

HLSPY $0.316 (-8.41%)

HMLSF $5.927 (1.65%)

HMPPF $0.498 (0%)

HRVOF $0.049 (1.14%)

HSTRF $0.090 (2.86%)

HUGE:CNX $1.750 (-1.69%)

IAN:CNX $0.120 (0%)

IGC $1.470 (14.84%)

IGXT $0.254 (15.28%)

IIPR $153.900 (1.28%)

INQD $0.001 (-8.33%)

IONC:CNX $0.015 (0%)

IONKF $0.016 (35.54%)

ISOL:CNX $0.025 (0%)

ISOLF $0.018 (0%)

ITHUF $0.092 (-4.43%)

IVITF $0.025 (0%)

JWCAF $0.002 (0%)

KBEV:CNX $0.055 (-8.33%)

KBEVF $0.044 (-5.46%)

KHRNF $0.339 (5.12%)

KSHB $0.718 (8.71%)

LHS:CNX $0.445 (-2.2%)

LHSIF $0.340 (-3.27%)

LOVE:CNX $0.080 (0%)

LXRP $0.200 (-2.87%)

LXX:CNX $0.265 (-1.85%)

MCIG $0.028 (0%)

MEDIF $0.400 (-4.65%)

MGWFF $0.043 (-14.9%)

MICWF $0.096 (-14.02%)

MJ:CNX $0.090 (-10%)

MJNA $0.017 (4.38%)

MNTR $0.092 (1.78%)

MRRCF $0.004 (-11.11%)

MWM:CNX $0.130 (-7.14%)

MYM:CNX $0.050 (-9.09%)

MYMMF $0.040 (2.56%)

NCNNF $0.120 (-2.81%)

NDVAF $0.167 (4.09%)

NGW:CNX $0.355 (2.9%)

NRXCF $0.109 (0%)

NSPDF $0.039 (22.64%)

NTEC $3.070 (-1.6%)

NWKRF $0.424 (0%)

NXGWF $0.278 (1.71%)

NXTTF $0.171 (-1.44%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.008 (-1.19%)

PHCG $0.419 (6.05%)

PHVAF $0.038 (0%)

PILL:CNX $0.650 (6.56%)

PKG:CNX $0.080 (6.67%)

PLPRF $0.430 (-1.22%)

PLUS:CNX $0.560 (-3.45%)

PMCB $0.006 (-12.5%)

PNPL $0.110 (0%)

POTN $0.006 (-33.33%)

PRCNF $0.010 (216.13%)

PTNYF $0.053 (-14.58%)

QCA:CNX $0.105 (0%)

RDDTF $0.076 (1.33%)

RLLVF $0.029 (0%)

RMHB $0.049 (-2%)

RQB:CNX $0.005 (0%)

RQHTF $0.202 (0.75%)

RVVQF $0.005 (-22.14%)

SLNG:CNX $0.270 (8%)

SMG $170.490 (0.69%)

SNN:CNX $0.155 (0%)

SNNVF $0.110 (12.82%)

SOL:CNX $2.340 (-4.1%)

SOLCF $1.790 (-4%)

SPLIF $0.008 (0%)

SPRWF $0.110 (1.85%)

SRNA $0.024 (1.69%)

STEM:CNX $0.510 (2%)

STMH $0.380 (-4.04%)

SUN:CNX $0.160 (-5.88%)

TBPMF $0.137 (-7.36%)

TCAN:CNX $0.820 (-4.65%)

TCNAF $0.623 (-0.22%)

TER:CNX $9.800 (0.1%)

TGEN $1.230 (3.36%)

TGIF:CNX $0.070 (-6.67%)

TGIFF $0.057 (-1.21%)

THC:CNX $0.080 (0%)

THCBF $0.060 (0.3%)

TLRY $6.680 (-9.24%)

TOKI:CNX $0.015 (0%)

TRLFF $0.080 (5.41%)

TRSSF $7.514 (-0.19%)

TRTC $0.092 (-3.26%)

TURV $0.069 (-9.11%)

VBIO $0.120 (-7.69%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.020 (0%)

VPRB $0.021 (2.5%)

VRNDF $0.445 (0.91%)

VRT:CNX $0.150 (0%)

VRTHF $0.115 (0%)

VVCIF $0.091 (-3.3%)

WAYL:CNX $0.740 (0%)

WDDMF $0.209 (-5.05%)

WLDFF $0.120 (-1.16%)

XXII $1.450 (7.41%)

ZDPY $0.405 (-11.96%)

ZYNE $4.160 (-1.42%)

Technical420 Site Search

Returned 78 result(s).

Despite A Massive Drop In Domestic Revenue, Medipharm Labs Has Several Catalysts For Growth On The International Side Of The Business

During the last month, we highlighted MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) as one of the most attractive ways to play the international cannabis market. Earlier this week, MediPharm Labs reported third quarter financial results that came in below expectations the market responded negatively to the numbers.…

MediPharm Labs Reports Third Quarter 2020 Results

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products today announced its financial results for the three and nine months ended September 30, 2020 and outlined its plan to accelerate growth and improve…

Medipharm Labs Is Looking To Capitalize On B2C In A Major Way Through LABS Cannabis

Early last week, MediPharm Labs (LABS) (MEDIF) reported a major development as it relates to the cannabis 2.0 market and announced the launch of a product line of family of health and wellness called LABS Cannabis. This represents a major change in direction for the business and we have always been…

Medipharm Labs Have Built The Foundation For A True Global Cannabis Oil Leader

During the last month, MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) has announced several strategic white-label supply agreement with cannabis companies that are levered to emerging international markets. MediPharm has been nothing short of a multi-national execution story and has more than 30 tolling and processing agreements with operators…

MediPharm Labs First to Launch THC-Free, 99% Pure CBD Isolate Consumer Sized Crystal in Canada

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the launch of LABS Cannabis CBD Isolate, the first in its LABS Cannabis branded product line and the first product of its kind in Canada. Designed…

MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release third quarter financial results for the three and nine month period ended September 30, 2020 before markets open on…

Medipharm Labs Forms Strategic Partnership To Execute On Clinical Trials Leveraging Proprietary Cannabis-Derived Formulations

Earlier this month, we highlighted MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) as an opportunity that is in the middle of a major transformation and is one that we are excited about. The Canadian cannabis company is considered to be a global leader in specialized, research-driven pharmaceutical-quality cannabis…

MediPharm Labs Enters New GMP Manufacturing Deal with Sunco Green Pharmaceutical Pty Ltd. in Australia

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary, MediPharm Labs Australia Pty Ltd, has entered into a new white-label supply agreement with Sunco Green Pharmaceutical Pty Ltd.. This marks MediPharm Labs’…

Medipharm Labs Is Trading At A Steep Discount To Its Peers Despite Transformational Changes Across Several Key Business Units

A few weeks ago, we issued an update on MediPharm Labs Corporation (LABS.TO) (MEDIF) after it expanded its presence on the international side of the industry. Through strategic agreements with leading operators in the European Union (EU) and South America, the company has significantly enhanced its growth prospects. Despite the…

MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the launch of its new “LABS Cannabis” family of health and wellness products. Specially designed and formulated for the Canadian consumers, the innovative and high-quality LABS…

Older Posts »

Search Again